
Blood draw
Syphilis VDRL/RPR
Measures non-specific antibodies that show how active a syphilis infection is. Mainly for monitoring treatment, alongside the TPHA.
€ 22,00
Your privacy
Necessary cookies keep the website working.
With your consent, we use additional cookies to:
We may share visited pages, interactions and device data with 5 service providers.
Hashed contact details are shared only with marketing consent.
You can change this later through Cookie preferences at the bottom of every page.
More information is available in our privacy policy.
Other analyses · Blood
Non-specific syphilis test that shows how active a syphilis infection is; mainly for monitoring treatment.
At a glance
Syphilis cardiolipin test (VDRL/RPR)
Explanation
Syphilis is an STI caused by the bacterium Treponema pallidum. This test looks for antibodies against fatty substances (cardiolipin) that are released when the bacterium damages tissue, and against fats from the bacterial wall. It is a so-called non-treponemal test: the antibodies are not specific to the syphilis bacterium, but they do say something about how active the infection is. The laboratory performs the test as a cardiolipin microflocculation test (CMT), a form of the VDRL, and with a positive result gives a titer (for example 1:16): the higher the titer, the more active the infection usually is.
Result
A positive result means that antibodies were found that react in this test. Together with a positive specific syphilis test, such as the TPHA, this usually fits an active or recently treated syphilis according to the LCI guideline (RIVM); the higher the titer, the more active the infection usually is. If the specific syphilis test is negative, the result is probably falsely positive, which occurs among other things in pregnancy, autoimmune diseases such as lupus (SLE), other infections, and at an older age. After successful treatment the titer usually falls slowly, but in some people a low titer remains detectable for a long time or for life.
A negative result means that no antibodies were found that react in this test. In the first weeks after infection, this test, like the other syphilis tests, is often still negative; when early syphilis is suspected, the LCI guideline (RIVM) advises repeating the blood test after 3, 6, and 12 weeks. Even with syphilis that has been present for years, this test can be negative while a specific syphilis test is positive. After treated syphilis, a negative result fits successful treatment.
With a positive result, a specific syphilis test and, if needed, a confirmation test follow, and the doctor also tests for HIV and other STIs. With active syphilis, treatment with antibiotics follows and sexual partners are informed, tested, and treated if needed; the titer from before treatment serves as the starting point for monitoring the effect. Individual cases of syphilis are not notifiable.
Reliability
According to the LCI guideline (RIVM), the non-treponemal test is a measure of how active the infection is and is used to monitor the effect of treatment; to detect syphilis, a specific (treponemal) test such as the TPHA is the first step, followed by a confirmation test and the non-treponemal test. After treatment, a fourfold fall in the titer is a sign that treatment is working, and a fourfold rise a possible sign of a new infection or failing treatment. Because the antibodies are not specific to the syphilis bacterium, falsely positive results occur and the result can only be interpreted alongside a specific syphilis test.
Who it is for
The test is mainly useful for people who have or had syphilis and have been treated, to see from the titer whether treatment is working or whether there is a new infection. When syphilis is suspected, such as with a painless sore or a non-itchy rash after sex, it says something about how active the infection is, but only alongside a specific syphilis test such as the TPHA. As the only test to find out whether you have syphilis, this test is not suitable; the test for syphilis antibodies (TPHA) is the first choice for that. Pregnant women are already tested routinely in the first trimester.
In the Netherlands, syphilis mainly occurs in men who have sex with men. In 2025, the sexual health centers diagnosed syphilis in 1,927 people; 91 percent of them were men who had sex with men. Syphilis is also more common in people with HIV.
RIVM (sexual health centers, 2025)
Get tested
Syphilis cardiolipin test (VDRL/RPR) is part of these test panels. You order online and have your blood drawn at a collection point or collect the sample at home.
Evidence
This explanation is based on Dutch guidelines and independent information. It is general information, not a diagnosis. Discuss an abnormal result with your GP.
More about risks and resultsMore explanations